stem cells in their environment

team >

clarisse ganier

nationality

French

role

PostDoctoral Research Associate

qualifications

  • PhD, Genetics, Paris Descartes University, France, 2018
  • MSc, Genetics, Paris Diderot University, France & La Sapienza University, Roma, Italy (double degree), 2015
  • European Magistere of Genetics, 2015

 

research project titles

  • ‘Generation of a Skin Cell Atlas for the Human Cell Atlas initiative’
  • ‘Cell therapy using the therapeutic potential of different fibroblasts subpopulations’

core expertise

  • Genomics
  • Bioinformatics
  • Genetics
  • Molecular biology
  • Cell biology
  • Flow cytometry and FACS
  • Confocal and Transmission electron microscopy,
  • Time-lapse microscopy
  • Tissue engineering
  • Animal experimentation

publications

  • 'Gradient boosting approaches can outperform logistic regression for risk prediction in cutaneous allergy.' Cunningham L, Ganier C, Ferguson F, White IR, Watt FM, McFadden J, Lynch MD. Contact Dermatitis. 2021 Nov 23. doi: 10.1111/cod.14011. Online ahead of print. PMID: 34812539 [PubMed]
  • 'Angiotensin-Converting Enzyme 2 Expression Is Detectable in Keratinocytes, Cutaneous Appendages, and Blood Vessels by Multiplex RNA in Situ Hybridization.' Ganier C, Harun N, Peplow I, Du-Harpur X, Arthurs C, Watt FM, Lynch MD. Adv Skin Wound Care. 2022 Jan 26. doi: 10.1097/01.ASW.0000819776.56007.18. Online ahead of print. PMID: 35085122 [PubMed]
  • 'Applications and future directions for optical coherence tomography in dermatology.' Wan B*, Ganier C*, Du-Harpur X, Harun N, Watt FM, Patalay R, Lynch MD. Br J Dermatol. 2020 Sep 24. doi: 10.1111/bjd.19553. PMID: 32974943 [PubMed]
  • 'Clinically-relevant vulnerabilities of deep machine learning systems for skin cancer diagnosis.' Du-Harpur X*, Arthurs C*, Ganier C, Woolf R, Laftah Z, Lakhan M, Salam A, Wan B, Watt FM, Luscombe NM, Lynch MD. J Invest Dermatol. 2020 Sep 12:S0022-202X(20)32056-X. doi: 10.1016/j.jid.2020.07.034. PMID: 32931808 [PubMed]
  • 'Emerging Technologies in Scar Management: The Role of Allogeneic Cells.' Ganier C. and Gaucher S. In Textbook on Scar Management: State of the Art Management and Emerging Technologies. 2020 Dec. Edited by Luc Téot, Thomas A. Mustoe, Esther Middelkoop, and Gerd G. Gauglitz, 451–55. Cham: Springer International Publishing.
  • 'Ethical Considerations: Scar Management.' Ganier C. and Gaucher S. In Textbook on Scar Management: State of the Art Management and Emerging Technologies. 2020 Dec. Edited by Luc Téot, Thomas A. Mustoe, Esther Middelkoop, and Gerd G. Gauglitz, 179–81. Cham: Springer International Publishing.
  • 'Gene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.' Gaucher S., Lwin SM., Titeux M., Abdul-Wahab A., Pironon N., Izmiryan A., Miskinyte S., Ganier C., Duchatelet S., Mellerio JE., Bourrat E., McGrath JA., Hovnanian A. EB Br J Dermatol. 2020 Mar;182(3):794-797 PMID: 31557321 [PubMed]
  • 'Ex vivo COL7A1 correction for Recessive Dystrophic Epidermolysis Bullosa using CRISPR/Cas9 and Homology Directed Repair.' Izmiryan A., Ganier C., Bovolenta M., Schmitt A., Mavilio F. and Hovnanian A. Mol Ther Nucleic Acids. 2018 Sep 7;12:554-567 PMID: 30195791 [PubMed]
  • 'Intradermal injection of bone marrow-MSC corrects Recessive Dystrophic Epidermolysis Bullosa in a xenograft model.' Ganier C., Titeux M., Gaucher S., Peltzer J., Le Lorc'h M., Lataillade JJ., Ishida-Yamamoto A., and Hovnanian A. J Invest Dermatol. 2018 Jul 11. pii: S0022-202X(18)31965-1 PMID: 29758284 [PubMed]
  • 'Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.' Jacków J., Titeux M., Portier S., Charbonnier S., Ganier C., Gaucher S., and Hovnanian A. J. Invest. Dermatol. 2016 Jul;136(7):1346-54 PMID: 26994967 [PubMed]